- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
data byte
e-health revenues rose more than 80% in 2000 compared with 1999, topping $1.7 billion last year, according to Seizing the eHealth Opportunity, a report published by Corporate Research Group. But losses increased at an even higher rate,
e-health revenues rose more than 80% in 2000 compared with 1999, topping $1.7 billion last year, according to Seizing the eHealth Opportunity, a report published by Corporate Research Group. But losses increased at an even higher rate, totaling $4 billion in 2000, a 400% increase over 1999. In addition, 2000 saw a corresponding decline in funds raised from public offerings: $484 million in the first nine months of 2000 versus $1.2 billion for the year in 1999.
CRG expects e-health revenues to continue to grow, topping $2.4 billion in 2001 and $3 billion in 2002, with most of the increases occurring in the connectivity and productivity markets. Content and e-commerce providers have the least chance of success in the e-health world, according to CRG, and market conditions will have a negative impact on the number of online pharmacies, supply chain vendors, and content providers.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
